FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.seltene |
| Resource Type | ValueSet |
| Id | ValueSet-mii-vs-seltene-nbs-target-analyte.json |
| FHIR Version | R4 |
| Source | https://medizininformatik-initiative.github.io/kerndatensatzmodul-seltene-erkrankungen/2027.0.0-ballot/ValueSet-mii-vs-seltene-nbs-target-analyte.html |
| URL | https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-target-analyte |
| Version | 2027.0.0-ballot |
| Status | active |
| Date | 2026-09-14T21:59:44+00:00 |
| Name | MII_VS_Seltene_NBS_TargetAnalyte |
| Title | MII VS Seltene Erkrankungen NBS Leitanalyten der Zielkrankheiten |
| Realm | de |
| Description | Leitanalyten der Zielkrankheiten des deutschen Neugeborenenscreenings nach G-BA Kinder-Richtlinie § 17 Abs. 1 (20 Zielkrankheiten) und 23 ff. (Mukoviszidose). Je Zielkrankheit der Analyt, über den sie im Screening erkannt wird. |
No resources found
| CodeSystem | ||
| kl.dk.fhir.children#2.1.0 | loinc.org | Logical Observation Identifiers, Names and Codes (LOINC) |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ValueSet mii-vs-seltene-nbs-target-analyte
Profiles: CRMI Shareable ValueSet, CRMI Publishable ValueSet
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 29575-8 | Thyrotropin [Units/volume] in DBS |
| 38473-5 | 17-Hydroxyprogesterone [Mass/volume] in DBS |
| 75217-0 | Biotinidase [Enzymatic activity/volume] in DBS |
| 54084-9 | Galactose [Mass/volume] in DBS |
| 29573-3 | Phenylalanine [Moles/volume] in DBS |
| 47679-6 | Leucine [Moles/volume] in DBS |
| 53175-6 | Octanoylcarnitine (C8) [Moles/volume] in DBS |
| 50125-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
| 53191-3 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
| 38481-8 | Carnitine free (C0) [Moles/volume] in DBS |
| 53199-6 | Palmitoylcarnitine (C16) [Moles/volume] in DBS |
| 53235-8 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
| 42920-9 | Isovalerylcarnitine (C5) [Moles/volume] in DBS |
| 53231-7 | Succinylacetone [Moles/volume] in DBS |
| 62320-7 | T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
| 54081-5 | Hemoglobinopathies newborn screening panel |
| 92002-5 | SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection |
| 53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS |
| 47700-0 | Methionine [Moles/volume] in DBS |
| 48633-2 | Trypsinogen I Free [Mass/volume] in DBS |
German
Generated Narrative: ValueSet mii-vs-seltene-nbs-target-analyte
Profiles: CRMI Shareable ValueSet, CRMI Publishable ValueSet
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 29575-8 | Thyrotropin [Units/volume] in DBS |
| 38473-5 | 17-Hydroxyprogesterone [Mass/volume] in DBS |
| 75217-0 | Biotinidase [Enzymatic activity/volume] in DBS |
| 54084-9 | Galactose [Mass/volume] in DBS |
| 29573-3 | Phenylalanine [Moles/volume] in DBS |
| 47679-6 | Leucine [Moles/volume] in DBS |
| 53175-6 | Octanoylcarnitine (C8) [Moles/volume] in DBS |
| 50125-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
| 53191-3 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
| 38481-8 | Carnitine free (C0) [Moles/volume] in DBS |
| 53199-6 | Palmitoylcarnitine (C16) [Moles/volume] in DBS |
| 53235-8 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
| 42920-9 | Isovalerylcarnitine (C5) [Moles/volume] in DBS |
| 53231-7 | Succinylacetone [Moles/volume] in DBS |
| 62320-7 | T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
| 54081-5 | Hemoglobinopathies newborn screening panel |
| 92002-5 | SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection |
| 53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS |
| 47700-0 | Methionine [Moles/volume] in DBS |
| 48633-2 | Trypsinogen I Free [Mass/volume] in DBS |
{
"resourceType": "ValueSet",
"id": "mii-vs-seltene-nbs-target-analyte",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "shareable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "publishable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "computable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes",
"code": "package",
"display": "Package"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-approvalDate",
"valueDate": "2026-09-02"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-topic",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C4873"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"telecom": [
{
"system": "email",
"value": "thomas.debertshaeuser@charite.de"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-editor",
"valueContactDetail": {
"name": "Taskforce Core Data Set"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
}
],
"url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-target-analyte",
"version": "2027.0.0-ballot",
"name": "MII_VS_Seltene_NBS_TargetAnalyte",
"title": "MII VS Seltene Erkrankungen NBS Leitanalyten der Zielkrankheiten",
"status": "active",
"experimental": false,
"date": "2026-09-14T21:59:44+00:00",
"publisher": "Medizininformatik Initiative",
"_publisher": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "de"
},
{
"url": "content",
"valueString": "Medizininformatik Initiative"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"contact": [
{
"name": "Medizininformatik Initiative",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/"
}
]
}
],
"description": "Leitanalyten der Zielkrankheiten des deutschen Neugeborenenscreenings nach G-BA Kinder-Richtlinie § 17 Abs. 1 (20 Zielkrankheiten) und 23 ff. (Mukoviszidose). Je Zielkrankheit der Analyt, über den sie im Screening erkannt wird.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "DE",
"display": "Germany"
}
]
}
],
"compose": {
"include": [
{
"system": "http://loinc.org",
"concept": [
{
"code": "29575-8",
"display": "Thyrotropin [Units/volume] in DBS"
},
{
"code": "38473-5",
"display": "17-Hydroxyprogesterone [Mass/volume] in DBS"
},
{
"code": "75217-0",
"display": "Biotinidase [Enzymatic activity/volume] in DBS"
},
{
"code": "54084-9",
"display": "Galactose [Mass/volume] in DBS"
},
{
"code": "29573-3",
"display": "Phenylalanine [Moles/volume] in DBS"
},
{
"code": "47679-6",
"display": "Leucine [Moles/volume] in DBS"
},
{
"code": "53175-6",
"display": "Octanoylcarnitine (C8) [Moles/volume] in DBS"
},
{
"code": "50125-4",
"display": "3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS"
},
{
"code": "53191-3",
"display": "Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS"
},
{
"code": "38481-8",
"display": "Carnitine free (C0) [Moles/volume] in DBS"
},
{
"code": "53199-6",
"display": "Palmitoylcarnitine (C16) [Moles/volume] in DBS"
},
{
"code": "53235-8",
"display": "Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS"
},
{
"code": "45207-8",
"display": "Glutarylcarnitine (C5-DC) [Moles/volume] in DBS"
},
{
"code": "42920-9",
"display": "Isovalerylcarnitine (C5) [Moles/volume] in DBS"
},
{
"code": "53231-7",
"display": "Succinylacetone [Moles/volume] in DBS"
},
{
"code": "62320-7",
"display": "T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection"
},
{
"code": "54081-5",
"display": "Hemoglobinopathies newborn screening panel"
},
{
"code": "92002-5",
"display": "SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection"
},
{
"code": "53160-8",
"display": "Propionylcarnitine (C3) [Moles/volume] in DBS"
},
{
"code": "47700-0",
"display": "Methionine [Moles/volume] in DBS"
},
{
"code": "48633-2",
"display": "Trypsinogen I Free [Mass/volume] in DBS"
}
]
}
]
}
}